Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study. (Q40903867)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Kazuaki Chayama

23

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

19

object named as

Michio Imamura

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

object named as

Hiroshi Aikata

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

17

object named as

Masataka Tsuge

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tomokazu Kawaoka

15

object named as

Tomokazu Kawaoka

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yoshiiku Kawakami

21

object named as

Yoshiiku Kawakami

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Akira Hiramatsu

18

object named as

Akira Hiramatsu

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Shoichi Takahashi

20

object named as

Shoichi Takahashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

22

object named as

Hidenori Ochi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Takashi Nakahara

14

object named as

Takashi Nakahara

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

object named as

Kei Morio

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

object named as

Hatsue Fujino

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

13

object named as

Atsushi Ono

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

object named as

Hiromi Kan

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tomoki Kobayashi

10

object named as

Tomoki Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Takayuki Fukuhara

11

object named as

Takayuki Fukuhara

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

object named as

Yuko Nagaoki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Norihito Nakano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Fumi Shinohara

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yuki Nakamura

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Masahiro Hatooka

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Keiichi Masaki

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hiroshima Liver Study Group

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1009-1015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Obesity and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Liver diseases and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

A high-throughput SNP typing system for genome-wide association studies

1 reference

https://api.crossref.org/works/10.1111%2FJGH.13236

21 January 2018

Identifiers

10.1111/JGH.13236

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584407%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40903867&oldid=1891009456"